Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Caina Technology Co Ltd
SZSE:301122
|
CN |
|
AAG Energy Holdings Ltd
HKEX:2686
|
HK |
|
Eternal Asia Supply Chain Management Ltd
SZSE:002183
|
CN |
Cumberland Pharmaceuticals Inc
Common Stock
Cumberland Pharmaceuticals Inc
Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
|
Common Stock
$51.7m
|
CAGR 3-Years
3%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-1%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Common Stock
$3.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Common Stock
$292m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
3%
|
|
|
Pfizer Inc
NYSE:PFE
|
Common Stock
$481m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Common Stock
$1.8B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Common Stock
$590m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-2%
|
|
Cumberland Pharmaceuticals Inc
Glance View
Cumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company, which engages in the acquisition, development, and commercialization of prescription products. The company is headquartered in Nashville, Tennessee and currently employs 83 full-time employees. The company went IPO on 2009-08-11. Its portfolio of brands includes Acetadote injection, for the treatment of acetaminophen poisoning; Caldolor injection, for the treatment of pain and fever; Kristalose for oral solution, a prescription laxative, for the treatment of constipation; and Omeclamox-Pak for the treatment of Helicobacter pylori (H. pylori) infection and related duodenal ulcer disease. Its brands also include RediTrex injection, for the treatment of active rheumatoid, juvenile idiopathic and severe psoriatic arthritis, as well as disabling psoriasis; Sancuso transdermal system, for the prevention of nausea and vomiting in patients receiving certain types of chemotherapy treatment; Vaprisol injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; and Vibativ injection.
See Also
What is Cumberland Pharmaceuticals Inc's Common Stock?
Common Stock
51.7m
USD
Based on the financial report for Dec 31, 2025, Cumberland Pharmaceuticals Inc's Common Stock amounts to 51.7m USD.
What is Cumberland Pharmaceuticals Inc's Common Stock growth rate?
Common Stock CAGR 10Y
-1%
Over the last year, the Common Stock growth was 10%. The average annual Common Stock growth rates for Cumberland Pharmaceuticals Inc have been 3% over the past three years , 1% over the past five years , and -1% over the past ten years .
